TTD | Drug: D0A8GM

Drug General Information
Drug ID	D0A8GM
Former ID	DNCL003469
Drug Name	Ublituximab
Synonyms	TG-1101
Drug Type	Antibody
Indication	Chronic lymphocytic leukaemia [ICD10:C91]		Phase 2	[549929]
Company	TG Therapeutics
Target and Pathway
Target(s)	B-lymphocyte antigen CD20	Target Info		[533097]
KEGG Pathway	Hematopoietic cell lineage
References
Ref 549929	Clinical pipeline report, company report or official report of TG THERAPEUTICS.
Ref 533097	The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenstr?m macroglobulinemia. Haematologica. 2015 Apr;100(4):e147-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information